Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adrenal Cortex Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05815069
What this trial is testing

[18F]AlF-NOTA-pentixather PET/CT in Patients With Suspected Primary Hyperaldosteronism

Who this might be right for
Primary HyperaldosteronismAldosterone-Producing Adenoma
Sichuan Provincial People's Hospital 20
Testing effectiveness (Phase 2)UnknownNCT04318730
What this trial is testing

Phase II Study for Combination of Camrelizumab and Apatinib in the Second-line Treatment of Recurrent or Metastatic Adrenocortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
West China Hospital 21
Not applicableUnknownNCT05763524
What this trial is testing

European Multicenter Study on Role of Lymph Node Dissection in Surgical Management of Adrenal Cortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 90
Testing effectiveness (Phase 2)WithdrawnNCT00469469
What this trial is testing

Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
Dartmouth-Hitchcock Medical Center
Large-scale testing (Phase 3)Looking for participantsNCT06888817
What this trial is testing

Bevacizumab Versus Corticosteroids as First-line Treatment in Patients With Symptomatic Cerebral Radiation Necrosis After Radiation for High-grade Glioma or Brain Metastases

Who this might be right for
Radiation NecrosisHigh Grade Glioma (III or IV)Brain Metastasases+4 more
The Netherlands Cancer Institute 408
Not applicableLooking for participantsNCT06065852
What this trial is testing

National Registry of Rare Kidney Diseases

Who this might be right for
Adenine Phosphoribosyltransferase DeficiencyAH AmyloidosisAHL Amyloidosis+81 more
UK Kidney Association 35,000
Testing effectiveness (Phase 2)Ended earlyNCT00002921
What this trial is testing

S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery

Who this might be right for
Adrenocortical Carcinoma
SWOG Cancer Research Network 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT02721732
What this trial is testing

Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic

Who this might be right for
Advanced Malignant Solid NeoplasmCarcinoma of Unknown PrimaryMetastatic Adrenal Gland Pheochromocytoma+16 more
M.D. Anderson Cancer Center 157
Not applicableUnknownNCT02030587
What this trial is testing

Laparoscopic Adrenalectomy Versus Radiofrequency Ablation

Who this might be right for
HyperaldosteronismConn SyndromeAdrenocortical Adenoma
Chinese University of Hong Kong 36
Not applicableLooking for participantsNCT07167251
What this trial is testing

Management of Immune Checkpoint Inhibition-related Hepatitis Using Low-dose Corticosteroids

Who this might be right for
Immune Related Adverse EventsImmune-Mediated HepatitisCancer
University Hospital, Basel, Switzerland 63
Early research (Phase 1)Looking for participantsNCT07189403
What this trial is testing

DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Advanced or Metastatic Adrenocortical CarcinomaMetastatic Castration-resistant Prostate Cancer
Daiichi Sankyo 40
Early research (Phase 1)WithdrawnNCT02831179
What this trial is testing

Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor

Who this might be right for
Functional Pancreatic Neuroendocrine TumorMalignant SomatostatinomaMerkel Cell Carcinoma+26 more
Vanderbilt-Ingram Cancer Center
Early research (Phase 1)Looking for participantsNCT06041516
What this trial is testing

A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors

Who this might be right for
Neuroendocrine CarcinomasNeuroendocrine TumorsCarcinoma, Neuroendocrine+2 more
National Cancer Institute (NCI) 70
Testing effectiveness (Phase 2)UnknownNCT00786110
What this trial is testing

Sorafenib Plus Paclitaxel in Adreno-Cortical-Cancer Patients

Who this might be right for
Adrenocortical Carcinoma
University of Turin, Italy 30
Not applicableLooking for participantsNCT06141369
What this trial is testing

Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)

Who this might be right for
Adrenal Cortical CarcinomaMedullary Thyroid CancerThymic Neuroendocrine Carcinoma+1 more
Shanghai Jiao Tong University School of Medicine 21
Not applicableUnknownNCT00997412
What this trial is testing

Trial of Mycophenolic Acid Versus Azathioprine in the Treatment of Corticosteroid-refractory Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Qualitix Clinical Research Co., Ltd. 40
Not applicableStudy completedNCT01234220
What this trial is testing

Adrenal Vein Sampling International Study (AVIS Study)

Who this might be right for
Hyperaldosteronism
University Hospital Padova 2,604
Post-approval studies (Phase 4)Study completedNCT00304447
What this trial is testing

Study Evaluating the Effect of Corticosteroids on Mylotarg® Infusion-Related Adverse Events in Patients With Leukemia

Who this might be right for
Leukemia, Myelocytic, AcuteInfusions, Intravenous
Wyeth is now a wholly owned subsidiary of Pfizer 30
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Ended earlyNCT04187404
What this trial is testing

A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma

Who this might be right for
Adrenocortical CarcinomaPheochromocytomaParaganglioma
Enterome 70
Next Page